AAAAAA

   
Results: 1-25 | 26-50 | 51-66 |
Results: 51-66/66

Authors: Stark, H Yang, YY Gurkan, D
Citation: H. Stark et al., Factors affecting convergence in the design of diffractive optics by iterative vector-space methods, J OPT SOC A, 16(1), 1999, pp. 149-159

Authors: Borstnik, A Stark, H Zumer, S
Citation: A. Borstnik et al., Interaction of spherical particles dispersed in a liquid crystal above thenematic-isotropic phase transition, PHYS REV E, 60(4), 1999, pp. 4210-4218

Authors: Stark, H Stelzer, J
Citation: H. Stark et J. Stelzer, Axially symmetric director configurations of inverted neiiiatic emulsions, MOL CRYST A, 329, 1999, pp. 987-994

Authors: Haddad, KC Stark, H Galatsanos, NP
Citation: Kc. Haddad et al., Design of digital linear-phase FIR crossover systems for loudspeakers by the method of vector space projections, IEEE SIGNAL, 47(11), 1999, pp. 3058-3066

Authors: Windhorst, AD Timmerman, H Klok, RP Custers, FGJ Menge, WMPB Leurs, R Stark, H Schunack, W Gielen, EGJ van Kroonenburgh, MJPG Herscheid, JDM
Citation: Ad. Windhorst et al., Radiosynthesis and biodistribution of I-123-labeled antagonists of the histamine H-3 receptor as potential SPECT ligands, NUCL MED BI, 26(6), 1999, pp. 651-659

Authors: Harms, J Tocilj, A Levin, I Agmon, I Stark, H Kolln, I van Heel, M Cuff, M Schlunzen, F Bashan, A Franceschi, F Yonath, A
Citation: J. Harms et al., Elucidating the medium-resolution structure of ribosomal particles: an interplay between electron cryo-microscopy and X-ray crystallography, STRUCT F D, 7(8), 1999, pp. 931-941

Authors: Stark, H
Citation: H. Stark, Isolated microscopic hematuria - is it a disease state?, PED NEPHROL, 13(5), 1999, pp. 468-468

Authors: Stark, H
Citation: H. Stark, The management of urinary tract infections, PED NEPHROL, 13(4), 1999, pp. 365-365

Authors: Stark, H Bischof, A Scheich, H
Citation: H. Stark et al., Increase of extracellular dopamine in prefrontal cortex of gerbils during acquisition of the avoidance strategy in the shuttle-box, NEUROSCI L, 264(1-3), 1999, pp. 77-80

Authors: Rudinger, A Stark, H
Citation: A. Rudinger et H. Stark, Twist transition in nematic droplets: a stability analysis, LIQ CRYST, 26(5), 1999, pp. 753-758

Authors: Matzanke, N Lowe, W Perachon, S Sokoloff, P Schwartz, JC Stark, H
Citation: N. Matzanke et al., Heterocyclic congeners of PD 128,907 with a partially hydrogenated benzomorpholine moiety as potential dopamine D-3-receptor ligands, EUR J MED C, 34(10), 1999, pp. 791-798

Authors: Sasse, A Kiec-Kononowicz, K Stark, H Motyl, M Reidemeister, S Ganellin, CR Ligneau, X Schwartz, JC Schunack, W
Citation: A. Sasse et al., Development of chiral N-alkylcarbamates as new leads for potent and selective H-3-receptor antagonists: Synthesis, capillary electrophoresis, and in vitro and oral in vivo activity, J MED CHEM, 42(4), 1999, pp. 593-600

Authors: Sasse, A Stark, H Reidemeister, S Huls, A Elz, S Ligneau, X Ganellin, CR Schwartz, JC Schunack, W
Citation: A. Sasse et al., Novel partial agonists for the histamine H-3 receptor with high in vitro and in vivo activity, J MED CHEM, 42(20), 1999, pp. 4269-4274

Authors: Bottcher, C Ludwig, K Herrmann, A van Heel, M Stark, H
Citation: C. Bottcher et al., Structure of influenza haemagglutinin at neutral and at fusogenic pH by electron cryo-microscopy, FEBS LETTER, 463(3), 1999, pp. 255-259

Authors: Krause, M Stark, H Schunack, W
Citation: M. Krause et al., Medicinal chemistry of histamine H-3 receptor agonists, PHARMCHEM L, 30, 1998, pp. 175-196

Authors: Kathmann, M Schlicker, E Marr, L Werthwein, S Stark, H Schunack, W
Citation: M. Kathmann et al., Ciproxifan and chemically related compounds are highly potent and selective histamine H-3-receptor antagonists, N-S ARCH PH, 358(6), 1998, pp. 623-627
Risultati: 1-25 | 26-50 | 51-66 |